Short answer
A BRCA VUS, or variant of uncertain significance, means a lab found a change in BRCA1 or BRCA2 but does not yet have enough evidence to say whether that change increases cancer risk. It is not the same as a pathogenic or likely pathogenic BRCA result. Until a VUS is reclassified, risk management should usually be based on personal history, family history, ancestry, and other established risk factors rather than the VUS alone.
What a BRCA VUS means
| Report wording | Practical meaning | Question to ask |
|---|---|---|
| Pathogenic or likely pathogenic BRCA variant | The lab found a variant known or strongly expected to raise cancer risk. | What screening, prevention, treatment, or family testing changes? |
| BRCA variant of uncertain significance | The variant was found, but the evidence is not enough to call it harmful or benign. | How should my care be guided by family history while this remains uncertain? |
| Negative BRCA result | No reportable harmful BRCA variant was found in the genes or variants tested. | Was this a true negative for a known family variant or an uninformative negative? |
| Tumor-only BRCA finding | The result may come from cancer tissue rather than inherited DNA. | Is separate germline testing needed to answer family-risk questions? |
What not to do from a VUS alone
- Do not treat a VUS as proof that you inherited hereditary breast and ovarian cancer syndrome.
- Do not assume relatives need targeted testing for the VUS as if it were a known family mutation.
- Do not use the VUS by itself as the reason for irreversible prevention decisions.
- Do not ignore family history; a strong family pattern can still change screening even when the BRCA result is uncertain or negative.
Why reclassification can change care
Labs periodically review VUS evidence as more families, case reports, and functional data accumulate. A VUS can later be reclassified as benign, likely benign, likely pathogenic, or pathogenic, but until that happens it should not be treated as a yes-or-no hereditary cancer answer. Ask whether the lab has a recontact policy and how the ordering clinician will be notified if the classification changes.
When the report needs context
A general lab reference can explain a VUS, but it cannot tell you whether the family pattern still warrants screening or whether another relative should test first. Family history, exact variant wording, and reclassification policy matter more than the VUS label alone.
Questions to bring to counseling
- What is the exact gene and variant notation on the report?
- Was this a clinical germline test, a direct-to-consumer result, or a tumor-only cancer test?
- Does the lab have a reclassification program, and how will I be notified if the VUS changes category?
- Would testing an affected relative, reviewing an older report, or using a broader hereditary cancer panel answer a clearer question?
- What screening plan makes sense from my personal and family history regardless of the VUS?
Related guides: BRCA testing vs broad cancer panels, hereditary cancer genetic testing, tumor genomic vs inherited genetic testing, and when to use a genetic counselor.
FAQ
Does a BRCA VUS mean I have hereditary breast and ovarian cancer?
No. A VUS is an uncertain finding, so it should not be treated as proof of a hereditary cancer syndrome.
Should relatives be tested for my BRCA VUS?
Not as if it were a known harmful family mutation. Family testing usually depends on whether the variant is later reclassified and on the broader family history.
Can a BRCA VUS become a positive result later?
Yes. Labs review new evidence over time, and a VUS can be reclassified if the evidence changes.
Should a BRCA VUS change surgery or screening by itself?
Usually no. Screening and prevention should still be guided by established risk factors, family history, and clinician advice.
What if my family history is strong even with a VUS?
Family history can still justify more careful screening or counseling even when the BRCA result is uncertain.
Who can explain the report and reclassification process?
A genetic counselor or the ordering clinician can explain the variant wording, possible reclassification, and the follow-up plan.